These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 28174249)

  • 1. Tracking the embryonic stem cell transition from ground state pluripotency.
    Kalkan T; Olova N; Roode M; Mulas C; Lee HJ; Nett I; Marks H; Walker R; Stunnenberg HG; Lilley KS; Nichols J; Reik W; Bertone P; Smith A
    Development; 2017 Apr; 144(7):1221-1234. PubMed ID: 28174249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of novel human ground state naive pluripotent stem cells.
    Gafni O; Weinberger L; Mansour AA; Manor YS; Chomsky E; Ben-Yosef D; Kalma Y; Viukov S; Maza I; Zviran A; Rais Y; Shipony Z; Mukamel Z; Krupalnik V; Zerbib M; Geula S; Caspi I; Schneir D; Shwartz T; Gilad S; Amann-Zalcenstein D; Benjamin S; Amit I; Tanay A; Massarwa R; Novershtern N; Hanna JH
    Nature; 2013 Dec; 504(7479):282-6. PubMed ID: 24172903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capturing pluripotency.
    Silva J; Smith A
    Cell; 2008 Feb; 132(4):532-6. PubMed ID: 18295569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the route from naive pluripotency to lineage specification.
    Kalkan T; Smith A
    Philos Trans R Soc Lond B Biol Sci; 2014 Dec; 369(1657):. PubMed ID: 25349449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation.
    Rostovskaya M; Stirparo GG; Smith A
    Development; 2019 Apr; 146(7):. PubMed ID: 30944104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells.
    Bao S; Tang F; Li X; Hayashi K; Gillich A; Lao K; Surani MA
    Nature; 2009 Oct; 461(7268):1292-5. PubMed ID: 19816418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-Molecule Induction of Canine Embryonic Stem Cells Toward Naïve Pluripotency.
    Tobias IC; Brooks CR; Teichroeb JH; Villagómez DA; Hess DA; Séguin CA; Betts DH
    Stem Cells Dev; 2016 Aug; 25(16):1208-22. PubMed ID: 27392793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of ground-state pluripotency by allelic regulation of Nanog.
    Miyanari Y; Torres-Padilla ME
    Nature; 2012 Feb; 483(7390):470-3. PubMed ID: 22327294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capture of Mouse and Human Stem Cells with Features of Formative Pluripotency.
    Kinoshita M; Barber M; Mansfield W; Cui Y; Spindlow D; Stirparo GG; Dietmann S; Nichols J; Smith A
    Cell Stem Cell; 2021 Mar; 28(3):453-471.e8. PubMed ID: 33271069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prdm14 promotes germline fate and naive pluripotency by repressing FGF signalling and DNA methylation.
    Grabole N; Tischler J; Hackett JA; Kim S; Tang F; Leitch HG; Magnúsdóttir E; Surani MA
    EMBO Rep; 2013 Jul; 14(7):629-37. PubMed ID: 23670199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formative pluripotency: the executive phase in a developmental continuum.
    Smith A
    Development; 2017 Feb; 144(3):365-373. PubMed ID: 28143843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotency Surveillance by Myc-Driven Competitive Elimination of Differentiating Cells.
    Díaz-Díaz C; Fernandez de Manuel L; Jimenez-Carretero D; Montoya MC; Clavería C; Torres M
    Dev Cell; 2017 Sep; 42(6):585-599.e4. PubMed ID: 28919206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zeb2 Regulates Cell Fate at the Exit from Epiblast State in Mouse Embryonic Stem Cells.
    Stryjewska A; Dries R; Pieters T; Verstappen G; Conidi A; Coddens K; Francis A; Umans L; van IJcken WF; Berx G; van Grunsven LA; Grosveld FG; Goossens S; Haigh JJ; Huylebroeck D
    Stem Cells; 2017 Mar; 35(3):611-625. PubMed ID: 27739137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxd3 Promotes Exit from Naive Pluripotency through Enhancer Decommissioning and Inhibits Germline Specification.
    Respuela P; Nikolić M; Tan M; Frommolt P; Zhao Y; Wysocka J; Rada-Iglesias A
    Cell Stem Cell; 2016 Jan; 18(1):118-33. PubMed ID: 26748758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency.
    Okashita N; Suwa Y; Nishimura O; Sakashita N; Kadota M; Nagamatsu G; Kawaguchi M; Kashida H; Nakajima A; Tachibana M; Seki Y
    Stem Cell Reports; 2016 Dec; 7(6):1072-1086. PubMed ID: 27866876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian Embryogenesis.
    Boroviak T; Loos R; Lombard P; Okahara J; Behr R; Sasaki E; Nichols J; Smith A; Bertone P
    Dev Cell; 2015 Nov; 35(3):366-82. PubMed ID: 26555056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states.
    Festuccia N; Osorno R; Wilson V; Chambers I
    Curr Opin Genet Dev; 2013 Oct; 23(5):504-11. PubMed ID: 23932125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omic Profiling Reveals Dynamics of the Phased Progression of Pluripotency.
    Yang P; Humphrey SJ; Cinghu S; Pathania R; Oldfield AJ; Kumar D; Perera D; Yang JYH; James DE; Mann M; Jothi R
    Cell Syst; 2019 May; 8(5):427-445.e10. PubMed ID: 31078527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin and identity of embryonic stem cells.
    Nichols J; Smith A
    Development; 2011 Jan; 138(1):3-8. PubMed ID: 21138972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Stem Cell Reporter for Investigating Pluripotency and Self-Renewal in the Rat.
    Meek S; Wei J; Oh T; Watson T; Olavarrieta J; Sutherland L; Carlson DF; Salzano A; Chandra T; Joshi A; Burdon T
    Stem Cell Reports; 2020 Jan; 14(1):154-166. PubMed ID: 31902707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.